Gene Symbol | Gene ID | Gene Info |
---|---|---|
PATZ1
|
ENSG00000100105.13 | POZ/BTB and AT hook containing zinc finger 1 |
KLF4
|
ENSG00000136826.10 | Kruppel like factor 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_110252508_110252968 | KLF4 | 25 | 0.981567 | 0.51 | 1.6e-01 | Click! |
chr9_110266526_110266677 | KLF4 | 13838 | 0.219811 | -0.46 | 2.1e-01 | Click! |
chr9_110311403_110311569 | KLF4 | 58723 | 0.128888 | -0.45 | 2.3e-01 | Click! |
chr9_110267439_110267590 | KLF4 | 14751 | 0.218552 | -0.33 | 3.9e-01 | Click! |
chr9_110251470_110251719 | KLF4 | 183 | 0.956539 | 0.27 | 4.8e-01 | Click! |
chr22_31739522_31739851 | PATZ1 | 2076 | 0.190582 | 0.87 | 2.4e-03 | Click! |
chr22_31739003_31739154 | PATZ1 | 2684 | 0.159557 | 0.75 | 2.0e-02 | Click! |
chr22_31739346_31739497 | PATZ1 | 2341 | 0.174473 | 0.73 | 2.5e-02 | Click! |
chr22_31737084_31737244 | PATZ1 | 4598 | 0.125107 | 0.71 | 3.2e-02 | Click! |
chr22_31736929_31737080 | PATZ1 | 4758 | 0.123761 | 0.68 | 4.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_145275512_145275663 | 2.01 |
ZEB2-AS1 |
ZEB2 antisense RNA 1 |
77 |
0.56 |
chr21_45230405_45230556 | 1.97 |
AP001053.11 |
|
238 |
0.92 |
chr17_42386672_42386888 | 1.83 |
RUNDC3A |
RUN domain containing 3A |
816 |
0.3 |
chr16_727114_727282 | 1.78 |
RHBDL1 |
rhomboid, veinlet-like 1 (Drosophila) |
1123 |
0.18 |
chr6_36684328_36684602 | 1.77 |
RAB44 |
RAB44, member RAS oncogene family |
1209 |
0.43 |
chr1_2431468_2431763 | 1.59 |
RP3-395M20.3 |
|
5697 |
0.11 |
chr1_154357957_154358230 | 1.57 |
IL6R |
interleukin 6 receptor |
19576 |
0.11 |
chr17_38078750_38078991 | 1.51 |
ORMDL3 |
ORM1-like 3 (S. cerevisiae) |
1586 |
0.26 |
chr19_55685507_55685658 | 1.49 |
SYT5 |
synaptotagmin V |
352 |
0.72 |
chr1_154980745_154981008 | 1.44 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
5581 |
0.08 |
chr19_1455635_1455880 | 1.42 |
APC2 |
adenomatosis polyposis coli 2 |
3560 |
0.08 |
chr1_27853864_27854219 | 1.41 |
RP1-159A19.4 |
|
1725 |
0.34 |
chr17_25659076_25659525 | 1.35 |
WSB1 |
WD repeat and SOCS box containing 1 |
37928 |
0.16 |
chr16_89188787_89189003 | 1.35 |
CTD-2555A7.3 |
|
7208 |
0.16 |
chr16_56894069_56894239 | 1.32 |
ENSG00000207649 |
. |
1724 |
0.27 |
chr14_105640706_105641069 | 1.29 |
JAG2 |
jagged 2 |
5726 |
0.18 |
chr16_27879052_27879203 | 1.27 |
ENSG00000212382 |
. |
4555 |
0.25 |
chr14_99698526_99698706 | 1.26 |
AL109767.1 |
|
30669 |
0.18 |
chr20_62183766_62184103 | 1.25 |
C20orf195 |
chromosome 20 open reading frame 195 |
439 |
0.69 |
chr1_151809574_151809991 | 1.25 |
C2CD4D |
C2 calcium-dependent domain containing 4D |
3251 |
0.1 |
chr17_17751315_17751466 | 1.24 |
SREBF1 |
sterol regulatory element binding transcription factor 1 |
11065 |
0.14 |
chr1_3371836_3372032 | 1.24 |
ARHGEF16 |
Rho guanine nucleotide exchange factor (GEF) 16 |
944 |
0.6 |
chr11_119561542_119562348 | 1.24 |
ENSG00000199217 |
. |
34924 |
0.14 |
chr22_50752388_50752886 | 1.23 |
XX-C283C717.1 |
|
423 |
0.69 |
chr14_24783456_24784225 | 1.22 |
LTB4R |
leukotriene B4 receptor |
66 |
0.91 |
chr1_154979701_154979987 | 1.22 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
4549 |
0.08 |
chr12_57631452_57631952 | 1.21 |
NDUFA4L2 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
581 |
0.57 |
chr10_103329534_103329705 | 1.20 |
DPCD |
deleted in primary ciliary dyskinesia homolog (mouse) |
787 |
0.61 |
chr11_117882452_117882916 | 1.19 |
IL10RA |
interleukin 10 receptor, alpha |
25575 |
0.15 |
chr2_740601_740858 | 1.19 |
AC092159.3 |
|
47494 |
0.15 |
chr16_68389761_68390217 | 1.19 |
SMPD3 |
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
14919 |
0.11 |
chr1_228074019_228074429 | 1.19 |
ENSG00000264483 |
. |
55160 |
0.1 |
chr14_105640411_105640562 | 1.18 |
JAG2 |
jagged 2 |
5325 |
0.18 |
chr15_41164512_41164663 | 1.18 |
RHOV |
ras homolog family member V |
1900 |
0.19 |
chr17_35293439_35293727 | 1.17 |
RP11-445F12.1 |
|
338 |
0.59 |
chr11_67177814_67178291 | 1.17 |
CARNS1 |
carnosine synthase 1 |
5097 |
0.07 |
chr12_58239763_58239914 | 1.17 |
CTDSP2 |
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 |
521 |
0.63 |
chr14_105949774_105950002 | 1.16 |
CRIP1 |
cysteine-rich protein 1 (intestinal) |
2766 |
0.15 |
chr15_31653722_31653873 | 1.16 |
KLF13 |
Kruppel-like factor 13 |
4560 |
0.34 |
chr7_158656716_158656867 | 1.16 |
WDR60 |
WD repeat domain 60 |
5346 |
0.27 |
chr17_42386389_42386620 | 1.16 |
RUNDC3A |
RUN domain containing 3A |
540 |
0.42 |
chr3_39192562_39192952 | 1.16 |
CSRNP1 |
cysteine-serine-rich nuclear protein 1 |
2309 |
0.28 |
chr2_241518694_241518905 | 1.16 |
RNPEPL1 |
arginyl aminopeptidase (aminopeptidase B)-like 1 |
3880 |
0.14 |
chr11_417677_417828 | 1.14 |
SIGIRR |
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
355 |
0.75 |
chr11_63728702_63728963 | 1.13 |
ENSG00000207200 |
. |
9110 |
0.11 |
chr1_154974037_154974188 | 1.13 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
1015 |
0.27 |
chr11_73680841_73681161 | 1.13 |
RP11-167N4.2 |
|
331 |
0.84 |
chr11_64125170_64125321 | 1.13 |
RPS6KA4 |
ribosomal protein S6 kinase, 90kDa, polypeptide 4 |
1375 |
0.23 |
chr20_37358980_37359131 | 1.12 |
SLC32A1 |
solute carrier family 32 (GABA vesicular transporter), member 1 |
5950 |
0.18 |
chr10_124907717_124907868 | 1.12 |
HMX2 |
H6 family homeobox 2 |
154 |
0.95 |
chr12_51985169_51985714 | 1.11 |
SCN8A |
sodium channel, voltage gated, type VIII, alpha subunit |
421 |
0.89 |
chr17_48277708_48277975 | 1.11 |
COL1A1 |
collagen, type I, alpha 1 |
289 |
0.84 |
chr20_62184229_62184720 | 1.10 |
C20orf195 |
chromosome 20 open reading frame 195 |
101 |
0.93 |
chr16_2028815_2028966 | 1.10 |
NOXO1 |
NADPH oxidase organizer 1 |
2294 |
0.08 |
chr3_47022966_47023797 | 1.10 |
CCDC12 |
coiled-coil domain containing 12 |
74 |
0.97 |
chr19_17859099_17859250 | 1.10 |
FCHO1 |
FCH domain only 1 |
603 |
0.64 |
chr6_108486750_108487194 | 1.10 |
OSTM1 |
osteopetrosis associated transmembrane protein 1 |
72 |
0.78 |
chr17_76531085_76531470 | 1.09 |
ENSG00000243426 |
. |
2140 |
0.28 |
chr11_64808327_64808521 | 1.09 |
SAC3D1 |
SAC3 domain containing 1 |
48 |
0.93 |
chr19_45667322_45667563 | 1.08 |
NKPD1 |
NTPase, KAP family P-loop domain containing 1 |
4034 |
0.12 |
chr8_144951585_144951858 | 1.08 |
EPPK1 |
epiplakin 1 |
911 |
0.41 |
chr2_172378816_172379017 | 1.08 |
CYBRD1 |
cytochrome b reductase 1 |
58 |
0.98 |
chr16_3233539_3233766 | 1.08 |
AJ003147.9 |
|
4560 |
0.11 |
chr16_85588898_85589049 | 1.08 |
GSE1 |
Gse1 coiled-coil protein |
56042 |
0.12 |
chr22_39602739_39602890 | 1.07 |
PDGFB |
platelet-derived growth factor beta polypeptide |
34100 |
0.11 |
chr9_139299169_139299735 | 1.07 |
SDCCAG3 |
serologically defined colon cancer antigen 3 |
2185 |
0.17 |
chr19_17952864_17953015 | 1.07 |
JAK3 |
Janus kinase 3 |
2317 |
0.18 |
chr3_50176036_50176295 | 1.07 |
SEMA3F |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F |
16313 |
0.12 |
chr8_144655209_144655539 | 1.07 |
MROH6 |
maestro heat-like repeat family member 6 |
233 |
0.51 |
chr2_173328771_173328938 | 1.07 |
AC078883.3 |
|
1886 |
0.32 |
chr10_62703240_62703501 | 1.06 |
RHOBTB1 |
Rho-related BTB domain containing 1 |
635 |
0.8 |
chr16_28947931_28948082 | 1.06 |
RABEP2 |
rabaptin, RAB GTPase binding effector protein 2 |
159 |
0.88 |
chr9_139000936_139001087 | 1.06 |
C9orf69 |
chromosome 9 open reading frame 69 |
9109 |
0.19 |
chr1_155052781_155052932 | 1.05 |
EFNA3 |
ephrin-A3 |
1471 |
0.2 |
chr3_50403492_50403986 | 1.05 |
XXcos-LUCA11.4 |
|
85 |
0.92 |
chr19_42463079_42463289 | 1.05 |
RABAC1 |
Rab acceptor 1 (prenylated) |
118 |
0.95 |
chr15_48937816_48938257 | 1.05 |
FBN1 |
fibrillin 1 |
10 |
0.99 |
chr16_27457393_27457546 | 1.05 |
IL21R-AS1 |
IL21R antisense RNA 1 |
7245 |
0.2 |
chr19_49713790_49713941 | 1.04 |
TRPM4 |
transient receptor potential cation channel, subfamily M, member 4 |
126 |
0.94 |
chr4_169552532_169552720 | 1.04 |
PALLD |
palladin, cytoskeletal associated protein |
140 |
0.97 |
chr22_42695306_42695687 | 1.04 |
TCF20 |
transcription factor 20 (AR1) |
44126 |
0.14 |
chr4_1606518_1606669 | 1.04 |
FAM53A |
family with sequence similarity 53, member A |
50542 |
0.12 |
chr10_70166213_70166490 | 1.03 |
RUFY2 |
RUN and FYVE domain containing 2 |
595 |
0.72 |
chr16_84769489_84769763 | 1.03 |
USP10 |
ubiquitin specific peptidase 10 |
32245 |
0.17 |
chr1_27468222_27468378 | 1.02 |
SLC9A1 |
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 |
12673 |
0.2 |
chr1_154988213_154988563 | 1.02 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
1464 |
0.18 |
chr8_21907130_21907348 | 1.02 |
DMTN |
dematin actin binding protein |
579 |
0.63 |
chr19_51228108_51228259 | 1.02 |
CLEC11A |
C-type lectin domain family 11, member A |
1403 |
0.27 |
chr1_98511108_98511385 | 1.02 |
ENSG00000225206 |
. |
339 |
0.94 |
chr18_53254709_53254980 | 1.02 |
TCF4 |
transcription factor 4 |
497 |
0.87 |
chr2_219866694_219866845 | 1.02 |
AC097468.4 |
|
168 |
0.67 |
chr16_727350_727692 | 1.02 |
RHBDL1 |
rhomboid, veinlet-like 1 (Drosophila) |
1446 |
0.13 |
chr16_30134090_30134241 | 1.02 |
MAPK3 |
mitogen-activated protein kinase 3 |
124 |
0.91 |
chr7_2549413_2549701 | 1.02 |
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
2606 |
0.23 |
chr19_12896860_12897296 | 1.01 |
ENSG00000263800 |
. |
864 |
0.31 |
chr20_3780673_3780933 | 1.01 |
CDC25B |
cell division cycle 25B |
3725 |
0.14 |
chr16_31142356_31142648 | 1.01 |
RP11-388M20.2 |
|
252 |
0.77 |
chr11_67079950_67080308 | 1.01 |
SSH3 |
slingshot protein phosphatase 3 |
5001 |
0.12 |
chr2_233186839_233187345 | 1.01 |
DIS3L2 |
DIS3 mitotic control homolog (S. cerevisiae)-like 2 |
11561 |
0.18 |
chr9_131661202_131661353 | 1.01 |
LRRC8A |
leucine rich repeat containing 8 family, member A |
16496 |
0.1 |
chr1_6306107_6306328 | 1.01 |
HES3 |
hes family bHLH transcription factor 3 |
1965 |
0.21 |
chr11_1858771_1859108 | 1.01 |
TNNI2 |
troponin I type 2 (skeletal, fast) |
1280 |
0.27 |
chr16_85678818_85679245 | 1.01 |
GSE1 |
Gse1 coiled-coil protein |
9007 |
0.17 |
chr4_775014_775218 | 1.01 |
RP11-440L14.1 |
|
502 |
0.7 |
chr1_2431041_2431419 | 1.01 |
RP3-395M20.3 |
|
5312 |
0.11 |
chr16_1392311_1392798 | 1.00 |
BAIAP3 |
BAI1-associated protein 3 |
2115 |
0.14 |
chr1_41966963_41967114 | 1.00 |
EDN2 |
endothelin 2 |
16696 |
0.19 |
chr10_82245535_82245824 | 1.00 |
TSPAN14 |
tetraspanin 14 |
26621 |
0.17 |
chr10_116303453_116303879 | 1.00 |
ABLIM1 |
actin binding LIM protein 1 |
16976 |
0.26 |
chr1_6485309_6485740 | 1.00 |
ESPN |
espin |
676 |
0.4 |
chr6_3159827_3159978 | 1.00 |
TUBB2A |
tubulin, beta 2A class IIa |
2142 |
0.24 |
chr17_30333890_30334183 | 1.00 |
LRRC37B |
leucine rich repeat containing 37B |
855 |
0.61 |
chr16_1350698_1351031 | 0.99 |
UBE2I |
ubiquitin-conjugating enzyme E2I |
8017 |
0.09 |
chr19_18315403_18315695 | 0.99 |
AC068499.10 |
|
2 |
0.91 |
chr19_892257_892574 | 0.99 |
MED16 |
mediator complex subunit 16 |
400 |
0.62 |
chr12_122072613_122072894 | 0.99 |
ORAI1 |
ORAI calcium release-activated calcium modulator 1 |
8032 |
0.18 |
chr11_125496038_125496275 | 0.99 |
CHEK1 |
checkpoint kinase 1 |
32 |
0.97 |
chr1_6209132_6209392 | 0.98 |
CHD5 |
chromodomain helicase DNA binding protein 5 |
30921 |
0.12 |
chr2_241771789_241771940 | 0.98 |
KIF1A |
kinesin family member 1A |
12139 |
0.17 |
chr17_3571236_3571438 | 0.98 |
TAX1BP3 |
Tax1 (human T-cell leukemia virus type I) binding protein 3 |
639 |
0.4 |
chr3_183416191_183416342 | 0.98 |
YEATS2 |
YEATS domain containing 2 |
660 |
0.73 |
chr11_13945360_13945725 | 0.98 |
ENSG00000201856 |
. |
16405 |
0.29 |
chr9_92445809_92446274 | 0.98 |
GADD45G |
growth arrest and DNA-damage-inducible, gamma |
226088 |
0.02 |
chr5_176799321_176799505 | 0.98 |
RGS14 |
regulator of G-protein signaling 14 |
5469 |
0.1 |
chr12_103888824_103889067 | 0.97 |
C12orf42 |
chromosome 12 open reading frame 42 |
786 |
0.73 |
chr19_872329_872946 | 0.97 |
CFD |
complement factor D (adipsin) |
12947 |
0.07 |
chr22_42696618_42697217 | 0.97 |
TCF20 |
transcription factor 20 (AR1) |
42705 |
0.15 |
chr1_2345297_2345527 | 0.97 |
PEX10 |
peroxisomal biogenesis factor 10 |
176 |
0.9 |
chr2_97626535_97626686 | 0.97 |
ENSG00000252845 |
. |
4058 |
0.18 |
chr17_43324320_43324639 | 0.97 |
CTD-2020K17.4 |
|
731 |
0.34 |
chr16_50729967_50730294 | 0.97 |
NOD2 |
nucleotide-binding oligomerization domain containing 2 |
920 |
0.44 |
chr16_68481521_68481833 | 0.97 |
SMPD3 |
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
718 |
0.63 |
chr1_204430993_204431895 | 0.97 |
PIK3C2B |
phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 beta |
5030 |
0.21 |
chr19_19649452_19649827 | 0.96 |
CILP2 |
cartilage intermediate layer protein 2 |
565 |
0.63 |
chr14_22966302_22966494 | 0.96 |
TRAJ51 |
T cell receptor alpha joining 51 (pseudogene) |
10227 |
0.1 |
chr17_72889150_72889301 | 0.96 |
FADS6 |
fatty acid desaturase 6 |
483 |
0.68 |
chr16_50644796_50644947 | 0.96 |
RP11-401P9.6 |
|
2724 |
0.24 |
chr20_61366242_61366424 | 0.95 |
RP11-93B14.4 |
|
366 |
0.81 |
chr16_85138387_85138827 | 0.95 |
FAM92B |
family with sequence similarity 92, member B |
7507 |
0.22 |
chr14_50469321_50469915 | 0.95 |
C14orf182 |
chromosome 14 open reading frame 182 |
4620 |
0.21 |
chr20_56192936_56193317 | 0.95 |
ZBP1 |
Z-DNA binding protein 1 |
2324 |
0.35 |
chr16_87888763_87888914 | 0.95 |
SLC7A5 |
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
8407 |
0.17 |
chr1_26861688_26862188 | 0.95 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
4119 |
0.17 |
chr8_144631891_144632307 | 0.95 |
RP11-661A12.5 |
|
200 |
0.84 |
chr11_57079046_57079197 | 0.95 |
TNKS1BP1 |
tankyrase 1 binding protein 1, 182kDa |
10550 |
0.11 |
chr6_8102779_8102930 | 0.95 |
EEF1E1 |
eukaryotic translation elongation factor 1 epsilon 1 |
43 |
0.98 |
chr10_47655231_47655487 | 0.95 |
ANTXRL |
anthrax toxin receptor-like |
2222 |
0.32 |
chr19_13266437_13266669 | 0.94 |
CTC-250I14.6 |
|
1546 |
0.23 |
chr19_35395777_35395928 | 0.94 |
ZNF30 |
zinc finger protein 30 |
21955 |
0.15 |
chr12_57483623_57484004 | 0.94 |
NAB2 |
NGFI-A binding protein 2 (EGR1 binding protein 2) |
923 |
0.39 |
chr1_21949529_21949680 | 0.94 |
RAP1GAP |
RAP1 GTPase activating protein |
593 |
0.74 |
chr8_97174029_97174180 | 0.94 |
GDF6 |
growth differentiation factor 6 |
1084 |
0.59 |
chr1_36771499_36771945 | 0.94 |
SH3D21 |
SH3 domain containing 21 |
266 |
0.89 |
chr12_54090523_54090879 | 0.94 |
CALCOCO1 |
calcium binding and coiled-coil domain 1 |
17712 |
0.15 |
chr15_32652772_32653196 | 0.94 |
ENSG00000221444 |
. |
32689 |
0.1 |
chr19_3054851_3055002 | 0.94 |
AC005944.2 |
|
2018 |
0.21 |
chr6_43701930_43702213 | 0.93 |
VEGFA |
vascular endothelial growth factor A |
35879 |
0.12 |
chr19_36202347_36202567 | 0.93 |
ZBTB32 |
zinc finger and BTB domain containing 32 |
1373 |
0.19 |
chr15_30469897_30470304 | 0.93 |
ENSG00000221785 |
. |
33020 |
0.11 |
chr17_73996453_73996604 | 0.93 |
CDK3 |
cyclin-dependent kinase 3 |
459 |
0.68 |
chr10_126849591_126849742 | 0.93 |
CTBP2 |
C-terminal binding protein 2 |
36 |
0.99 |
chr5_177543276_177543552 | 0.93 |
N4BP3 |
NEDD4 binding protein 3 |
2970 |
0.23 |
chr12_111831727_111831878 | 0.93 |
SH2B3 |
SH2B adaptor protein 3 |
11950 |
0.18 |
chr1_3820226_3820752 | 0.92 |
C1orf174 |
chromosome 1 open reading frame 174 |
3640 |
0.21 |
chr17_27943894_27944206 | 0.92 |
CORO6 |
coronin 6 |
1085 |
0.28 |
chr12_54783002_54783412 | 0.92 |
ZNF385A |
zinc finger protein 385A |
1858 |
0.19 |
chr19_35705150_35705432 | 0.92 |
FAM187B |
family with sequence similarity 187, member B |
14341 |
0.1 |
chr18_45754753_45754968 | 0.91 |
AC091150.1 |
HCG1818186; Uncharacterized protein |
23812 |
0.19 |
chr15_77287160_77287311 | 0.91 |
PSTPIP1 |
proline-serine-threonine phosphatase interacting protein 1 |
191 |
0.95 |
chr8_145061442_145061593 | 0.91 |
PARP10 |
poly (ADP-ribose) polymerase family, member 10 |
168 |
0.89 |
chr4_7973111_7973262 | 0.91 |
AFAP1 |
actin filament associated protein 1 |
31533 |
0.14 |
chr11_61582787_61582938 | 0.91 |
FADS1 |
fatty acid desaturase 1 |
99 |
0.55 |
chr14_69286304_69286455 | 0.91 |
ZFP36L1 |
ZFP36 ring finger protein-like 1 |
23189 |
0.18 |
chr21_44835236_44835488 | 0.91 |
SIK1 |
salt-inducible kinase 1 |
11646 |
0.28 |
chr19_19043797_19044162 | 0.91 |
HOMER3 |
homer homolog 3 (Drosophila) |
5812 |
0.1 |
chr12_69864753_69865036 | 0.91 |
FRS2 |
fibroblast growth factor receptor substrate 2 |
680 |
0.74 |
chr21_46830873_46831024 | 0.91 |
COL18A1-AS2 |
COL18A1 antisense RNA 2 |
968 |
0.5 |
chr7_22122886_22123037 | 0.90 |
RAPGEF5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
110566 |
0.07 |
chr6_37023589_37023822 | 0.90 |
COX6A1P2 |
cytochrome c oxidase subunit VIa polypeptide 1 pseudogene 2 |
11098 |
0.2 |
chr1_153265189_153265437 | 0.90 |
PGLYRP3 |
peptidoglycan recognition protein 3 |
17881 |
0.11 |
chr2_27071961_27072112 | 0.90 |
DPYSL5 |
dihydropyrimidinase-like 5 |
660 |
0.72 |
chr3_71481312_71481831 | 0.90 |
ENSG00000221264 |
. |
109669 |
0.06 |
chr11_2912733_2913001 | 0.90 |
SLC22A18AS |
solute carrier family 22 (organic cation transporter), member 18 antisense |
2207 |
0.19 |
chr2_26990361_26990533 | 0.90 |
SLC35F6 |
solute carrier family 35, member F6 |
3290 |
0.23 |
chr2_97561847_97562072 | 0.90 |
FAM178B |
family with sequence similarity 178, member B |
1911 |
0.27 |
chr15_90605469_90605716 | 0.89 |
ZNF710 |
zinc finger protein 710 |
5654 |
0.16 |
chr12_57635535_57635686 | 0.89 |
NDUFA4L2 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
1135 |
0.31 |
chr1_156450769_156450960 | 0.89 |
MEF2D |
myocyte enhancer factor 2D |
2358 |
0.19 |
chr2_24272218_24272506 | 0.89 |
C2orf44 |
chromosome 2 open reading frame 44 |
83 |
0.67 |
chr13_113380151_113380343 | 0.89 |
ENSG00000264726 |
. |
8019 |
0.2 |
chr11_3185463_3185685 | 0.88 |
OSBPL5 |
oxysterol binding protein-like 5 |
79 |
0.96 |
chr21_45715243_45715525 | 0.88 |
PFKL |
phosphofructokinase, liver |
4550 |
0.11 |
chr9_130906009_130906346 | 0.88 |
LCN2 |
lipocalin 2 |
5173 |
0.09 |
chr1_155293017_155293168 | 0.88 |
RUSC1 |
RUN and SH3 domain containing 1 |
636 |
0.39 |
chr19_45753774_45754062 | 0.88 |
MARK4 |
MAP/microtubule affinity-regulating kinase 4 |
598 |
0.65 |
chr17_77180372_77180523 | 0.88 |
RBFOX3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
893 |
0.66 |
chr16_403840_404259 | 0.88 |
AXIN1 |
axin 1 |
1390 |
0.27 |
chr17_79886052_79886276 | 0.88 |
MAFG-AS1 |
MAFG antisense RNA 1 (head to head) |
113 |
0.8 |
chr17_3868599_3869062 | 0.88 |
ATP2A3 |
ATPase, Ca++ transporting, ubiquitous |
1094 |
0.51 |
chr2_227663405_227663664 | 0.88 |
IRS1 |
insulin receptor substrate 1 |
941 |
0.59 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.1 | 1.1 | GO:0061054 | dermatome development(GO:0061054) |
0.9 | 4.7 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.8 | 2.5 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.8 | 0.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.7 | 8.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.7 | 2.2 | GO:0001743 | optic placode formation(GO:0001743) |
0.7 | 2.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.7 | 2.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.7 | 2.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.7 | 2.1 | GO:0010511 | regulation of phosphatidylinositol biosynthetic process(GO:0010511) |
0.7 | 2.1 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.6 | 2.5 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.6 | 1.2 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.6 | 4.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.6 | 0.6 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.6 | 3.0 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.6 | 1.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.6 | 1.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.6 | 4.6 | GO:0007172 | signal complex assembly(GO:0007172) |
0.6 | 1.7 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.6 | 2.8 | GO:0061430 | bone trabecula formation(GO:0060346) bone trabecula morphogenesis(GO:0061430) |
0.6 | 1.7 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.6 | 1.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.6 | 2.2 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.5 | 1.6 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.5 | 0.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.5 | 0.5 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.5 | 2.2 | GO:1903960 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.5 | 0.5 | GO:0002363 | alpha-beta T cell lineage commitment(GO:0002363) |
0.5 | 0.5 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.5 | 0.5 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
0.5 | 1.6 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.5 | 3.2 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.5 | 2.6 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.5 | 1.6 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.5 | 1.6 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) dendritic cell migration(GO:0036336) |
0.5 | 0.5 | GO:0048664 | neuron fate determination(GO:0048664) |
0.5 | 0.5 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.5 | 0.5 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.5 | 3.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.5 | 1.5 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.5 | 1.5 | GO:0001705 | ectoderm formation(GO:0001705) |
0.5 | 0.5 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.5 | 1.5 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.5 | 1.5 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.5 | 1.5 | GO:0010159 | specification of organ position(GO:0010159) |
0.5 | 0.5 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.5 | 1.5 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.5 | 1.0 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.5 | 0.5 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
0.5 | 2.9 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.5 | 1.4 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.5 | 0.5 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.5 | 0.5 | GO:0072033 | renal vesicle formation(GO:0072033) |
0.5 | 1.9 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.5 | 0.9 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.5 | 1.4 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.5 | 0.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.5 | 1.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.5 | 1.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.4 | 0.9 | GO:0044415 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.4 | 1.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.4 | 0.9 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.4 | 0.8 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.4 | 1.3 | GO:0061043 | vascular wound healing(GO:0061042) regulation of vascular wound healing(GO:0061043) |
0.4 | 1.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.4 | 0.4 | GO:0044268 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.4 | 0.8 | GO:1903825 | organic acid transmembrane transport(GO:1903825) carboxylic acid transmembrane transport(GO:1905039) |
0.4 | 1.2 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.4 | 2.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 1.6 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.4 | 1.2 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
0.4 | 0.8 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.4 | 0.4 | GO:0071223 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.4 | 0.4 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.4 | 1.6 | GO:0045586 | gamma-delta T cell differentiation(GO:0042492) regulation of gamma-delta T cell differentiation(GO:0045586) positive regulation of gamma-delta T cell differentiation(GO:0045588) regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.4 | 1.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.4 | 1.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.4 | 1.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.4 | 2.0 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
0.4 | 1.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.4 | 2.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.4 | 0.8 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.4 | 2.3 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.4 | 0.8 | GO:0070293 | renal absorption(GO:0070293) |
0.4 | 0.4 | GO:0015802 | basic amino acid transport(GO:0015802) |
0.4 | 0.4 | GO:0098801 | regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
0.4 | 0.7 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 1.9 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.4 | 1.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 1.5 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.4 | 1.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.4 | 1.5 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.4 | 1.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.4 | 0.4 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) positive regulation of killing of cells of other organism(GO:0051712) |
0.4 | 0.4 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) regulation of NFAT protein import into nucleus(GO:0051532) |
0.4 | 0.4 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.4 | 0.4 | GO:0050931 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
0.4 | 3.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.4 | 1.4 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.4 | 0.7 | GO:0060430 | lung saccule development(GO:0060430) Type II pneumocyte differentiation(GO:0060510) |
0.4 | 1.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 0.4 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.4 | 1.1 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.4 | 1.8 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.3 | 2.8 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.3 | 1.0 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.3 | 0.7 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
0.3 | 0.3 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
0.3 | 1.4 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 1.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.3 | 1.0 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.3 | 2.1 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.3 | 0.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.3 | 0.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.3 | 1.4 | GO:0051798 | positive regulation of hair cycle(GO:0042635) regulation of hair follicle development(GO:0051797) positive regulation of hair follicle development(GO:0051798) |
0.3 | 2.4 | GO:0030903 | notochord development(GO:0030903) |
0.3 | 1.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.3 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.3 | 5.0 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.3 | 0.3 | GO:0015809 | arginine transport(GO:0015809) |
0.3 | 0.3 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.3 | 2.6 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.3 | 0.7 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.3 | 1.0 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 0.3 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.3 | 1.3 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.3 | 1.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.3 | 0.3 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.3 | 1.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.3 | 0.6 | GO:0050856 | regulation of antigen receptor-mediated signaling pathway(GO:0050854) regulation of T cell receptor signaling pathway(GO:0050856) negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.3 | 0.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 1.0 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.3 | 1.0 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
0.3 | 1.3 | GO:0000089 | mitotic metaphase(GO:0000089) |
0.3 | 0.3 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.3 | 1.6 | GO:0033235 | regulation of protein sumoylation(GO:0033233) positive regulation of protein sumoylation(GO:0033235) |
0.3 | 0.6 | GO:0032730 | regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
0.3 | 0.3 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.3 | 0.3 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.3 | 1.6 | GO:0097094 | cranial suture morphogenesis(GO:0060363) craniofacial suture morphogenesis(GO:0097094) |
0.3 | 0.9 | GO:0031034 | skeletal muscle myosin thick filament assembly(GO:0030241) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 0.6 | GO:0046717 | acid secretion(GO:0046717) |
0.3 | 0.6 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 1.9 | GO:0043368 | positive T cell selection(GO:0043368) |
0.3 | 0.9 | GO:1904019 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.3 | 0.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.3 | 1.2 | GO:0090200 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
0.3 | 0.9 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.3 | 3.0 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
0.3 | 2.4 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 2.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 0.6 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.3 | 0.3 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) positive regulation of metanephros development(GO:0072216) |
0.3 | 1.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.3 | 0.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 1.5 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.3 | 1.5 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.3 | 1.5 | GO:0060438 | trachea development(GO:0060438) |
0.3 | 1.7 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 1.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 0.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.3 | 2.6 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.3 | 0.6 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.3 | 1.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.3 | 0.9 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 1.2 | GO:0018101 | protein citrullination(GO:0018101) |
0.3 | 1.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 0.3 | GO:0045933 | positive regulation of muscle contraction(GO:0045933) |
0.3 | 1.1 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 1.7 | GO:0010288 | response to lead ion(GO:0010288) |
0.3 | 0.9 | GO:0010447 | response to acidic pH(GO:0010447) |
0.3 | 0.9 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.3 | 0.8 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
0.3 | 1.4 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.3 | 6.9 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.3 | 0.8 | GO:0071392 | cellular response to estradiol stimulus(GO:0071392) |
0.3 | 3.3 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.3 | 0.6 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.3 | 0.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.3 | 0.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.3 | 0.8 | GO:0000279 | M phase(GO:0000279) |
0.3 | 1.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.3 | 0.3 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.3 | 0.8 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.3 | 0.5 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.3 | 1.1 | GO:0050685 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.3 | 0.5 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.3 | 0.8 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.3 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.3 | 1.1 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.3 | 0.3 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 0.8 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.3 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 0.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.3 | 1.1 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 1.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.3 | 1.1 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.3 | 6.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 0.5 | GO:0008049 | male courtship behavior(GO:0008049) |
0.3 | 0.3 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.3 | 1.6 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.3 | 1.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.3 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.3 | 0.5 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.3 | 1.3 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.3 | 0.5 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.3 | 0.8 | GO:0097502 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.3 | 0.8 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.3 | 0.3 | GO:0010842 | retina layer formation(GO:0010842) |
0.3 | 0.8 | GO:0006562 | proline catabolic process(GO:0006562) |
0.3 | 0.8 | GO:0018119 | protein nitrosylation(GO:0017014) peptidyl-cysteine S-nitrosylation(GO:0018119) |
0.3 | 0.8 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.3 | 0.5 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.3 | 0.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.3 | 1.5 | GO:0006983 | ER overload response(GO:0006983) |
0.3 | 1.0 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.3 | 0.5 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.3 | 2.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.3 | 0.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.3 | 3.8 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.2 | 0.2 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 1.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.2 | 1.5 | GO:0051294 | establishment of mitotic spindle orientation(GO:0000132) establishment of spindle orientation(GO:0051294) |
0.2 | 0.7 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 1.0 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 0.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 0.2 | GO:1902742 | apoptotic process involved in development(GO:1902742) |
0.2 | 1.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 1.2 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.2 | 0.5 | GO:1901797 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.2 | 0.5 | GO:0006925 | inflammatory cell apoptotic process(GO:0006925) |
0.2 | 0.7 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.5 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.2 | 0.7 | GO:0046666 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.2 | 0.5 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) |
0.2 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.7 | GO:0002323 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.2 | 0.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.2 | 0.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.2 | 0.7 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.2 | 1.4 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.2 | 1.0 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.2 | 0.5 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 0.5 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 2.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.2 | 0.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 0.2 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.2 | 0.7 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 0.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.7 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 2.6 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.2 | 11.1 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.2 | 0.7 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.2 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.7 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.2 | 0.2 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.2 | 2.1 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.2 | 0.2 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.2 | 0.7 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.2 | 0.9 | GO:0034227 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.2 | 1.4 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.2 | 0.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 0.2 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.2 | 0.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 2.3 | GO:0031648 | protein destabilization(GO:0031648) |
0.2 | 0.2 | GO:0060055 | angiogenesis involved in wound healing(GO:0060055) |
0.2 | 0.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.2 | 0.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.2 | 0.2 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.2 | 0.2 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) sodium ion homeostasis(GO:0055078) |
0.2 | 0.2 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.2 | 1.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 1.5 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
0.2 | 0.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.9 | GO:0021548 | pons development(GO:0021548) |
0.2 | 0.6 | GO:0070828 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.2 | 1.1 | GO:0046320 | regulation of fatty acid metabolic process(GO:0019217) regulation of fatty acid oxidation(GO:0046320) |
0.2 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.2 | 0.4 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.2 | 0.4 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) layer formation in cerebral cortex(GO:0021819) telencephalon glial cell migration(GO:0022030) |
0.2 | 0.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.2 | 0.2 | GO:0051593 | response to folic acid(GO:0051593) |
0.2 | 1.5 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.2 | 0.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) regulation of gamma-aminobutyric acid secretion(GO:0014052) gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 1.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.2 | 1.3 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.2 | 2.5 | GO:0042993 | positive regulation of transcription factor import into nucleus(GO:0042993) |
0.2 | 1.3 | GO:0048103 | somatic stem cell division(GO:0048103) |
0.2 | 0.8 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.2 | 1.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.2 | 0.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 0.8 | GO:0051882 | mitochondrial depolarization(GO:0051882) |
0.2 | 1.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.2 | 0.4 | GO:0006922 | obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
0.2 | 0.4 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.2 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 1.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 0.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.2 | 1.0 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.2 | 0.2 | GO:0031664 | regulation of lipopolysaccharide-mediated signaling pathway(GO:0031664) |
0.2 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 0.2 | GO:1901862 | negative regulation of muscle tissue development(GO:1901862) |
0.2 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 1.0 | GO:0008347 | glial cell migration(GO:0008347) |
0.2 | 0.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.2 | 0.6 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.6 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 4.1 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.2 | 0.8 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.2 | 0.6 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.2 | 2.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 4.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 0.2 | GO:0071801 | regulation of podosome assembly(GO:0071801) positive regulation of podosome assembly(GO:0071803) |
0.2 | 0.2 | GO:0050432 | catecholamine secretion(GO:0050432) |
0.2 | 0.6 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
0.2 | 1.8 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 2.4 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.2 | 1.6 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) positive regulation of neuron death(GO:1901216) |
0.2 | 0.6 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
0.2 | 1.2 | GO:0071295 | cellular response to vitamin(GO:0071295) |
0.2 | 1.6 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.2 | 1.6 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.2 | 0.6 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.2 | 1.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.2 | 0.8 | GO:0006560 | proline metabolic process(GO:0006560) |
0.2 | 0.2 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.2 | 0.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.2 | 0.4 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.2 | 1.0 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.6 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.2 | 1.4 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.2 | 1.6 | GO:0010039 | response to iron ion(GO:0010039) |
0.2 | 0.4 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.2 | 1.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.2 | 0.4 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.2 | 0.8 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.2 | 0.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.6 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
0.2 | 0.8 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 0.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 2.9 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.2 | 0.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.2 | 1.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 0.2 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.2 | 2.5 | GO:1901800 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
0.2 | 0.4 | GO:0090399 | replicative senescence(GO:0090399) |
0.2 | 0.2 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) |
0.2 | 0.4 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.2 | 0.6 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.2 | 0.4 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.2 | 0.4 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.2 | 0.6 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 0.7 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.2 | 1.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 0.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 0.6 | GO:0045911 | positive regulation of isotype switching(GO:0045830) positive regulation of DNA recombination(GO:0045911) |
0.2 | 0.2 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.2 | 1.1 | GO:0030901 | midbrain development(GO:0030901) |
0.2 | 1.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.2 | 0.4 | GO:0001961 | positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
0.2 | 0.4 | GO:0031622 | regulation of fever generation(GO:0031620) positive regulation of fever generation(GO:0031622) |
0.2 | 0.9 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.2 | 0.6 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.7 | GO:0055023 | positive regulation of cardiac muscle tissue growth(GO:0055023) positive regulation of cardiac muscle tissue development(GO:0055025) positive regulation of cardiac muscle cell proliferation(GO:0060045) |
0.2 | 0.9 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.2 | 0.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.2 | 1.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.2 | 0.2 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 1.5 | GO:0016925 | protein sumoylation(GO:0016925) |
0.2 | 0.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.4 | GO:0060294 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.2 | 0.4 | GO:0071692 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.2 | 0.4 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.2 | 0.4 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.2 | 1.8 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.2 | 0.7 | GO:0031062 | positive regulation of histone methylation(GO:0031062) |
0.2 | 1.4 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 0.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.4 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.2 | 0.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 0.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.2 | 0.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.4 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.2 | 0.4 | GO:0032098 | regulation of appetite(GO:0032098) |
0.2 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 1.6 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.2 | 0.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.9 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 0.4 | GO:0043441 | acetoacetic acid biosynthetic process(GO:0043441) |
0.2 | 0.2 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.2 | 2.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 0.9 | GO:0007616 | long-term memory(GO:0007616) |
0.2 | 0.3 | GO:0006828 | manganese ion transport(GO:0006828) |
0.2 | 0.9 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.2 | 0.2 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.2 | 0.5 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.2 | 7.5 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.2 | 0.5 | GO:0009180 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.2 | 1.7 | GO:0060359 | response to ammonium ion(GO:0060359) |
0.2 | 0.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.9 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.2 | 0.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 3.7 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.2 | 0.9 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.2 | 0.5 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.2 | 0.2 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.2 | 1.2 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.2 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.2 | GO:0043276 | anoikis(GO:0043276) |
0.2 | 0.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.2 | 0.5 | GO:0009301 | snRNA transcription(GO:0009301) |
0.2 | 1.0 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 0.5 | GO:0051014 | actin filament severing(GO:0051014) |
0.2 | 0.8 | GO:0030163 | protein catabolic process(GO:0030163) |
0.2 | 2.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.2 | GO:0060596 | mammary placode formation(GO:0060596) |
0.2 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 0.2 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.3 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.2 | 0.2 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.2 | 0.8 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.2 | 0.2 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.2 | 0.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.2 | 1.0 | GO:0035121 | obsolete tail morphogenesis(GO:0035121) |
0.2 | 0.3 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
0.2 | 1.0 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.2 | 0.6 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.2 | 0.8 | GO:0048240 | sperm capacitation(GO:0048240) |
0.2 | 0.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 0.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 0.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.2 | 0.3 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.2 | 3.3 | GO:0046847 | filopodium assembly(GO:0046847) |
0.2 | 1.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.2 | 1.1 | GO:0009304 | tRNA transcription(GO:0009304) |
0.2 | 0.3 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.2 | 2.3 | GO:0007566 | embryo implantation(GO:0007566) |
0.2 | 0.2 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
0.2 | 2.5 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.2 | 0.5 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 0.2 | GO:0071800 | podosome assembly(GO:0071800) |
0.2 | 0.6 | GO:0000154 | rRNA modification(GO:0000154) |
0.2 | 1.4 | GO:0051322 | anaphase(GO:0051322) |
0.2 | 0.8 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.2 | 2.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.2 | 3.0 | GO:0030837 | negative regulation of actin filament polymerization(GO:0030837) |
0.2 | 0.5 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.2 | 0.3 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
0.2 | 0.6 | GO:0010458 | exit from mitosis(GO:0010458) |
0.2 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.2 | 0.2 | GO:0060513 | prostatic bud formation(GO:0060513) |
0.1 | 0.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 1.3 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.1 | 0.1 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) negative regulation of cell killing(GO:0031342) |
0.1 | 1.3 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.1 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 1.0 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.9 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.1 | 0.1 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.1 | 0.3 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 0.4 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0000723 | telomere maintenance(GO:0000723) |
0.1 | 0.1 | GO:0002360 | T cell lineage commitment(GO:0002360) |
0.1 | 0.1 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.4 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.1 | 1.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.1 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 0.1 | GO:0002437 | inflammatory response to antigenic stimulus(GO:0002437) |
0.1 | 1.3 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 2.3 | GO:0007032 | endosome organization(GO:0007032) |
0.1 | 0.7 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.4 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.1 | 3.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.3 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.1 | 0.4 | GO:0045007 | depurination(GO:0045007) |
0.1 | 0.1 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
0.1 | 1.1 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.1 | 1.0 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.1 | 0.4 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 1.5 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) dendritic cell differentiation(GO:0097028) |
0.1 | 1.3 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 1.7 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.1 | 0.1 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
0.1 | 0.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 0.1 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 7.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.1 | 0.1 | GO:0098656 | anion transmembrane transport(GO:0098656) |
0.1 | 0.1 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.1 | 0.7 | GO:0034311 | diol metabolic process(GO:0034311) |
0.1 | 0.1 | GO:0030072 | peptide hormone secretion(GO:0030072) |
0.1 | 0.4 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.1 | 0.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 1.2 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.1 | 0.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 1.5 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.1 | 2.7 | GO:0019079 | viral genome replication(GO:0019079) |
0.1 | 0.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.5 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.3 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.4 | GO:0043122 | regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
0.1 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0002327 | immature B cell differentiation(GO:0002327) pre-B cell differentiation(GO:0002329) |
0.1 | 0.4 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.1 | 0.5 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.1 | 0.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.1 | GO:0046173 | inositol phosphate biosynthetic process(GO:0032958) polyol biosynthetic process(GO:0046173) |
0.1 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.1 | 0.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 0.1 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.5 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.5 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 0.5 | GO:0060761 | negative regulation of response to cytokine stimulus(GO:0060761) |
0.1 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.3 | GO:1902579 | multi-organism transport(GO:0044766) transport of virus(GO:0046794) intracellular transport of virus(GO:0075733) multi-organism localization(GO:1902579) multi-organism intracellular transport(GO:1902583) |
0.1 | 4.7 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.1 | 4.5 | GO:0046782 | regulation of viral transcription(GO:0046782) positive regulation of viral transcription(GO:0050434) |
0.1 | 0.4 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 1.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.1 | 0.4 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
0.1 | 0.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:0090266 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.3 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.3 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 0.1 | GO:0006168 | adenine salvage(GO:0006168) purine nucleobase salvage(GO:0043096) adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
0.1 | 0.1 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.1 | 0.5 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.1 | 0.3 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 0.8 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 1.7 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.8 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.1 | 1.8 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.1 | 1.5 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.1 | 0.3 | GO:0031116 | positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 0.1 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.1 | 0.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 0.1 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.1 | 0.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.5 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.6 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.5 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 1.0 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.1 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.1 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.1 | 0.1 | GO:0052251 | induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) |
0.1 | 0.2 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 0.4 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.7 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.1 | GO:0032342 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) |
0.1 | 1.5 | GO:0016575 | histone deacetylation(GO:0016575) |
0.1 | 1.1 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.1 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 1.3 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.4 | GO:0032306 | regulation of icosanoid secretion(GO:0032303) positive regulation of icosanoid secretion(GO:0032305) regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) prostaglandin secretion(GO:0032310) |
0.1 | 5.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.1 | 0.5 | GO:0046040 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.1 | 0.5 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 1.3 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
0.1 | 0.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.1 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.4 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 1.0 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.1 | 0.7 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.2 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.1 | 3.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 0.6 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
0.1 | 2.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.9 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 0.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.8 | GO:0045471 | response to ethanol(GO:0045471) |
0.1 | 0.2 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
0.1 | 0.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.6 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.1 | GO:0051957 | positive regulation of amino acid transport(GO:0051957) |
0.1 | 0.5 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.2 | GO:0050663 | cytokine secretion(GO:0050663) |
0.1 | 0.3 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 2.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 1.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.3 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.1 | 0.3 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.1 | 1.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.2 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.7 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.5 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 3.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.5 | GO:0006476 | protein deacetylation(GO:0006476) |
0.1 | 1.0 | GO:0042471 | ear morphogenesis(GO:0042471) |
0.1 | 0.1 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.2 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.1 | 0.9 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.1 | GO:0070076 | histone lysine demethylation(GO:0070076) |
0.1 | 1.0 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.1 | 4.0 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.2 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.9 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.3 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.1 | 0.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.2 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 0.1 | GO:0001841 | neural tube formation(GO:0001841) |
0.1 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 1.0 | GO:0090114 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
0.1 | 0.2 | GO:0071436 | sodium ion export(GO:0071436) |
0.1 | 0.8 | GO:0051403 | stress-activated MAPK cascade(GO:0051403) |
0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.1 | 0.1 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.1 | 0.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.6 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.1 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.3 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.1 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 1.9 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.1 | 0.1 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
0.1 | 0.2 | GO:0070265 | necrotic cell death(GO:0070265) |
0.1 | 0.2 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
0.1 | 0.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.1 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.4 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.1 | 0.1 | GO:0048565 | digestive tract development(GO:0048565) |
0.1 | 0.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.3 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.2 | GO:0060021 | palate development(GO:0060021) |
0.1 | 0.6 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.1 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.1 | 0.1 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.2 | GO:0002889 | regulation of B cell mediated immunity(GO:0002712) regulation of immunoglobulin mediated immune response(GO:0002889) |
0.1 | 0.3 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.1 | 0.5 | GO:1902749 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.1 | 0.3 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.2 | GO:0048645 | organ formation(GO:0048645) |
0.1 | 0.5 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.1 | 0.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 1.6 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.1 | 0.7 | GO:0009145 | nucleoside triphosphate biosynthetic process(GO:0009142) purine nucleoside triphosphate biosynthetic process(GO:0009145) |
0.1 | 2.2 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.1 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 0.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.4 | GO:0072676 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.1 | 0.5 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.6 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.1 | 0.7 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 | 0.2 | GO:0015838 | quaternary ammonium group transport(GO:0015697) amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 0.2 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.1 | GO:0014015 | positive regulation of gliogenesis(GO:0014015) |
0.1 | 0.1 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) |
0.1 | 0.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 0.4 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
0.1 | 0.3 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 1.2 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.1 | GO:0051961 | negative regulation of nervous system development(GO:0051961) |
0.1 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.1 | 1.0 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.1 | 0.8 | GO:0060678 | dichotomous subdivision of terminal units involved in ureteric bud branching(GO:0060678) |
0.1 | 0.6 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.1 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) anatomical structure regression(GO:0060033) |
0.1 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.1 | GO:0071320 | cellular response to cAMP(GO:0071320) |
0.1 | 0.5 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 0.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.6 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.1 | 0.6 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.1 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.1 | 0.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.1 | 1.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.2 | GO:0051789 | obsolete response to protein(GO:0051789) |
0.1 | 0.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.1 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 0.1 | GO:0021675 | nerve development(GO:0021675) |
0.1 | 0.5 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
0.1 | 0.1 | GO:0085029 | extracellular matrix assembly(GO:0085029) |
0.1 | 1.3 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 2.3 | GO:0030819 | positive regulation of cAMP metabolic process(GO:0030816) positive regulation of cAMP biosynthetic process(GO:0030819) |
0.1 | 0.2 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.1 | 0.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.1 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.1 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 1.7 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 0.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 1.9 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.1 | GO:0050686 | negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.1 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.2 | GO:1903513 | endoplasmic reticulum to cytosol transport(GO:1903513) |
0.1 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 0.4 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.1 | 0.2 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 1.1 | GO:0022408 | negative regulation of cell-cell adhesion(GO:0022408) |
0.1 | 0.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.1 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.1 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.1 | 0.1 | GO:0043113 | receptor clustering(GO:0043113) |
0.1 | 0.2 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.8 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.3 | GO:0034620 | endoplasmic reticulum unfolded protein response(GO:0030968) cellular response to unfolded protein(GO:0034620) |
0.1 | 0.2 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) |
0.1 | 0.5 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.1 | 0.2 | GO:0014044 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.5 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.3 | GO:0031929 | TOR signaling(GO:0031929) |
0.1 | 0.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.4 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 0.3 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 5.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 3.7 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.1 | 0.1 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.3 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 0.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.1 | GO:0032106 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.1 | 0.8 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.1 | 0.2 | GO:0055006 | cardiac cell development(GO:0055006) cardiac muscle cell development(GO:0055013) |
0.1 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 2.6 | GO:0033559 | unsaturated fatty acid metabolic process(GO:0033559) |
0.1 | 0.2 | GO:0034653 | isoprenoid catabolic process(GO:0008300) vitamin catabolic process(GO:0009111) diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) fat-soluble vitamin catabolic process(GO:0042363) |
0.1 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.2 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.9 | GO:0021517 | ventral spinal cord development(GO:0021517) |
0.1 | 0.2 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
0.1 | 0.4 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.1 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.1 | 0.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 1.5 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 0.2 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 0.7 | GO:0007140 | male meiosis(GO:0007140) |
0.1 | 1.0 | GO:0051324 | prophase(GO:0051324) |
0.1 | 1.1 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.1 | 0.2 | GO:0001952 | regulation of cell-matrix adhesion(GO:0001952) |
0.1 | 0.5 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.1 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 1.1 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.1 | 0.2 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.6 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.1 | 0.2 | GO:0006448 | regulation of translational elongation(GO:0006448) |
0.1 | 1.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.3 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 1.1 | GO:1904029 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
0.1 | 0.3 | GO:0045768 | obsolete positive regulation of anti-apoptosis(GO:0045768) |
0.1 | 0.5 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.3 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.1 | 0.2 | GO:0030516 | regulation of axon extension(GO:0030516) |
0.1 | 0.6 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.1 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.1 | 0.2 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 4.4 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.1 | 0.2 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.9 | GO:0016073 | snRNA metabolic process(GO:0016073) |
0.1 | 0.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.1 | 0.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.2 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.1 | 0.3 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.2 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
0.1 | 0.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.1 | 0.2 | GO:0042023 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.1 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.2 | GO:0032722 | positive regulation of chemokine production(GO:0032722) |
0.1 | 0.4 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.8 | GO:0006298 | mismatch repair(GO:0006298) |
0.1 | 0.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.5 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
0.1 | 0.4 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.3 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.1 | 0.1 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.1 | 5.2 | GO:0006364 | rRNA processing(GO:0006364) |
0.1 | 0.7 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.1 | 0.4 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 0.1 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.1 | 1.1 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.6 | GO:0042044 | fluid transport(GO:0042044) |
0.1 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.4 | GO:0008213 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.1 | 0.1 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.1 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 1.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 1.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.4 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.1 | GO:0031334 | positive regulation of protein complex assembly(GO:0031334) |
0.1 | 0.4 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.1 | 0.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.6 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 2.2 | GO:0006914 | autophagy(GO:0006914) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 0.2 | GO:0045682 | regulation of epidermis development(GO:0045682) |
0.1 | 0.3 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.1 | 1.9 | GO:0071774 | cellular response to fibroblast growth factor stimulus(GO:0044344) response to fibroblast growth factor(GO:0071774) |
0.1 | 0.4 | GO:0042596 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
0.1 | 0.1 | GO:0030641 | regulation of cellular pH(GO:0030641) |
0.1 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 1.2 | GO:0007416 | synapse assembly(GO:0007416) |
0.1 | 0.3 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.2 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.6 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.2 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
0.1 | 0.1 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
0.1 | 0.4 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.1 | 0.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.5 | GO:0043174 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) nucleoside salvage(GO:0043174) |
0.1 | 0.1 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) |
0.1 | 0.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 0.1 | GO:0048538 | thymus development(GO:0048538) |
0.1 | 0.1 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.1 | 0.3 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.1 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.1 | 0.2 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.1 | GO:0046326 | positive regulation of glucose import(GO:0046326) |
0.1 | 0.1 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.1 | 0.7 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.1 | 0.1 | GO:0071503 | response to heparin(GO:0071503) |
0.1 | 0.4 | GO:0016051 | carbohydrate biosynthetic process(GO:0016051) |
0.1 | 0.4 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.1 | 0.1 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.1 | 0.9 | GO:0034249 | negative regulation of translation(GO:0017148) negative regulation of cellular amide metabolic process(GO:0034249) |
0.1 | 0.4 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.3 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 0.3 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
0.1 | 0.3 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.1 | 0.6 | GO:0032368 | regulation of lipid transport(GO:0032368) |
0.1 | 0.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.1 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.2 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.1 | 0.1 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.2 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.1 | 0.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.9 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.1 | 0.6 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.4 | GO:0034332 | adherens junction organization(GO:0034332) |
0.1 | 0.4 | GO:0033673 | negative regulation of kinase activity(GO:0033673) |
0.1 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 6.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.1 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.1 | 3.2 | GO:0070085 | glycosylation(GO:0070085) |
0.1 | 1.9 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 0.1 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.1 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 6.7 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.1 | 1.9 | GO:0006631 | fatty acid metabolic process(GO:0006631) |
0.1 | 0.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.1 | 1.3 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.1 | 0.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.8 | GO:0007041 | lysosomal transport(GO:0007041) |
0.1 | 0.1 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.3 | GO:0046348 | amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 5.1 | GO:0022900 | electron transport chain(GO:0022900) |
0.1 | 2.0 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.1 | 0.1 | GO:0072698 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.1 | 2.6 | GO:0006959 | humoral immune response(GO:0006959) |
0.1 | 11.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.1 | 1.7 | GO:0042110 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.1 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.6 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.1 | 0.1 | GO:0001776 | leukocyte homeostasis(GO:0001776) |
0.1 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.8 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.1 | 9.8 | GO:0016568 | chromatin modification(GO:0016568) |
0.1 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 2.6 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.1 | GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032434) |
0.1 | 0.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.1 | 0.1 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
0.1 | 1.9 | GO:0060337 | response to type I interferon(GO:0034340) type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 0.8 | GO:0006903 | vesicle targeting(GO:0006903) |
0.1 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.4 | GO:0045851 | pH reduction(GO:0045851) |
0.1 | 0.2 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
0.1 | 0.1 | GO:0031503 | protein complex localization(GO:0031503) |
0.1 | 0.3 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.1 | 0.1 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
0.1 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.1 | GO:0048771 | tissue remodeling(GO:0048771) |
0.1 | 0.1 | GO:0071229 | cellular response to acid chemical(GO:0071229) |
0.1 | 2.5 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.1 | 0.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 1.0 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.1 | 1.2 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.3 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.1 | 1.2 | GO:0015718 | monocarboxylic acid transport(GO:0015718) |
0.1 | 0.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.1 | 1.8 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.4 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 3.5 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.1 | 0.6 | GO:0070304 | positive regulation of stress-activated protein kinase signaling cascade(GO:0070304) |
0.1 | 0.2 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.1 | 0.8 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.1 | 0.2 | GO:0090068 | positive regulation of cell cycle process(GO:0090068) |
0.1 | 0.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 12.4 | GO:0043043 | peptide biosynthetic process(GO:0043043) |
0.1 | 0.1 | GO:1903306 | negative regulation of regulated secretory pathway(GO:1903306) |
0.1 | 2.0 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.1 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.1 | 0.1 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.1 | 0.2 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.4 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.1 | GO:0060479 | lung cell differentiation(GO:0060479) |
0.1 | 0.1 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.1 | GO:0070509 | calcium ion import(GO:0070509) |
0.1 | 1.3 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) cell cycle G2/M phase transition(GO:0044839) |
0.1 | 0.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.2 | GO:0061008 | hepaticobiliary system development(GO:0061008) |
0.1 | 0.9 | GO:0010952 | positive regulation of peptidase activity(GO:0010952) |
0.1 | 3.8 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.0 | 1.6 | GO:0034470 | ncRNA processing(GO:0034470) |
0.0 | 0.1 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.5 | GO:0045666 | positive regulation of neuron differentiation(GO:0045666) |
0.0 | 4.3 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.0 | 0.1 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.5 | GO:0006518 | peptide metabolic process(GO:0006518) |
0.0 | 0.0 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.0 | 0.5 | GO:0001843 | neural tube closure(GO:0001843) |
0.0 | 0.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.3 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.0 | 4.7 | GO:0016032 | viral process(GO:0016032) multi-organism cellular process(GO:0044764) |
0.0 | 0.0 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 3.7 | GO:0006325 | chromatin organization(GO:0006325) |
0.0 | 0.1 | GO:0033003 | regulation of mast cell activation(GO:0033003) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.0 | GO:1903578 | regulation of glycolytic process(GO:0006110) regulation of nucleoside metabolic process(GO:0009118) regulation of nucleotide catabolic process(GO:0030811) regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) regulation of ATP metabolic process(GO:1903578) |
0.0 | 0.0 | GO:0043247 | telomere capping(GO:0016233) protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
0.0 | 0.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.0 | 0.1 | GO:0048599 | oocyte differentiation(GO:0009994) oocyte development(GO:0048599) |
0.0 | 0.7 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
0.0 | 0.1 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.0 | 0.5 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.0 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
0.0 | 0.0 | GO:0072091 | regulation of stem cell proliferation(GO:0072091) |
0.0 | 0.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 0.0 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.3 | GO:0006073 | cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.0 | 3.9 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.0 | 0.3 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.0 | 0.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.0 | GO:0003032 | detection of oxygen(GO:0003032) |
0.0 | 0.6 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.0 | 0.3 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.1 | GO:0017157 | regulation of exocytosis(GO:0017157) |
0.0 | 0.5 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.0 | 0.1 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.0 | 0.3 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.3 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.0 | 0.0 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.0 | 0.1 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.0 | 0.4 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.0 | 0.1 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
0.0 | 0.9 | GO:0048534 | hematopoietic or lymphoid organ development(GO:0048534) |
0.0 | 0.2 | GO:0043473 | pigmentation(GO:0043473) |
0.0 | 2.1 | GO:0006869 | lipid transport(GO:0006869) |
0.0 | 0.2 | GO:0051297 | centrosome organization(GO:0051297) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.0 | 0.0 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
0.0 | 0.0 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.0 | 0.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.0 | GO:0042158 | lipoprotein biosynthetic process(GO:0042158) |
0.0 | 0.5 | GO:0050680 | negative regulation of epithelial cell proliferation(GO:0050680) |
0.0 | 0.0 | GO:0002703 | regulation of leukocyte mediated immunity(GO:0002703) |
0.0 | 0.4 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 3.2 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
0.0 | 0.6 | GO:0060538 | skeletal muscle organ development(GO:0060538) |
0.0 | 0.6 | GO:0044275 | cellular carbohydrate catabolic process(GO:0044275) |
0.0 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.3 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.0 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 2.2 | GO:0016042 | lipid catabolic process(GO:0016042) |
0.0 | 1.2 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.0 | 0.1 | GO:0042311 | vasodilation(GO:0042311) |
0.0 | 0.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.0 | 0.1 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 1.9 | GO:0007018 | microtubule-based movement(GO:0007018) |
0.0 | 0.3 | GO:0009309 | amine biosynthetic process(GO:0009309) |
0.0 | 0.5 | GO:0044782 | cilium organization(GO:0044782) |
0.0 | 0.6 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.0 | 0.1 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.3 | GO:0061025 | membrane fusion(GO:0061025) |
0.0 | 0.8 | GO:0009179 | purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) |
0.0 | 0.1 | GO:0043543 | protein acylation(GO:0043543) |
0.0 | 0.0 | GO:0015853 | nucleobase transport(GO:0015851) adenine transport(GO:0015853) |
0.0 | 0.2 | GO:0098781 | ncRNA transcription(GO:0098781) |
0.0 | 0.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.3 | GO:0071554 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.0 | 0.2 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.0 | 0.1 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.3 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.0 | 0.7 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.0 | 0.5 | GO:0006909 | phagocytosis(GO:0006909) |
0.0 | 0.1 | GO:0031668 | cellular response to extracellular stimulus(GO:0031668) |
0.0 | 0.2 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.1 | GO:0015813 | acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
0.0 | 0.5 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.6 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.0 | 0.1 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.6 | GO:0006397 | mRNA processing(GO:0006397) |
0.0 | 0.1 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.1 | GO:0009755 | hormone-mediated signaling pathway(GO:0009755) |
0.0 | 0.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.0 | 0.0 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
0.0 | 0.5 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.3 | GO:0007204 | positive regulation of cytosolic calcium ion concentration(GO:0007204) |
0.0 | 0.5 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 1.1 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 9.4 | GO:0015031 | protein transport(GO:0015031) |
0.0 | 0.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.0 | 0.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 22.0 | GO:0032774 | RNA biosynthetic process(GO:0032774) |
0.0 | 0.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.0 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.0 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.0 | 0.0 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.0 | 0.0 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.2 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.0 | 0.0 | GO:0045165 | cell fate commitment(GO:0045165) |
0.0 | 1.8 | GO:0006814 | sodium ion transport(GO:0006814) |
0.0 | 0.1 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.3 | GO:0002526 | acute inflammatory response(GO:0002526) |
0.0 | 0.8 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 8.7 | GO:0006508 | proteolysis(GO:0006508) |
0.0 | 0.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.0 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.0 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.0 | 0.1 | GO:0051346 | negative regulation of hydrolase activity(GO:0051346) |
0.0 | 0.1 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.0 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.0 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.0 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 1.2 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.1 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.0 | 0.0 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.0 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.3 | GO:0009100 | glycoprotein metabolic process(GO:0009100) |
0.0 | 0.3 | GO:0001503 | ossification(GO:0001503) |
0.0 | 0.1 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.0 | 0.0 | GO:0032880 | regulation of protein localization(GO:0032880) |
0.0 | 0.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.0 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.0 | 0.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.0 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.1 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 0.0 | GO:0048678 | response to axon injury(GO:0048678) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 0.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.9 | 3.4 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.7 | 2.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.7 | 0.7 | GO:0070938 | contractile ring(GO:0070938) |
0.6 | 1.8 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.5 | 1.6 | GO:0072487 | MSL complex(GO:0072487) |
0.5 | 1.6 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.5 | 0.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.4 | 1.7 | GO:0070820 | tertiary granule(GO:0070820) |
0.4 | 1.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.4 | 0.8 | GO:0044448 | cell cortex part(GO:0044448) |
0.4 | 1.6 | GO:0042583 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.4 | 1.2 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.4 | 0.4 | GO:0031941 | filamentous actin(GO:0031941) |
0.4 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.4 | 1.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 1.5 | GO:0043218 | compact myelin(GO:0043218) |
0.4 | 1.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 1.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.3 | 2.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.3 | 1.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 0.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 1.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 4.5 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 1.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 0.9 | GO:0033270 | paranode region of axon(GO:0033270) |
0.3 | 0.9 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.3 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.3 | 0.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.3 | 2.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 1.7 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 1.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.3 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 1.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 5.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 1.1 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.3 | 0.8 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.3 | 1.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.3 | 0.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 1.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 1.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.3 | 0.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 0.5 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.3 | 0.8 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 2.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 1.0 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.3 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.3 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 2.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 1.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 2.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.0 | GO:0016580 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.2 | 3.4 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.2 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 1.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.2 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.2 | 1.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.2 | 0.5 | GO:0044462 | external encapsulating structure part(GO:0044462) |
0.2 | 0.9 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 0.7 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 4.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.2 | 0.7 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 1.3 | GO:0005883 | neurofilament(GO:0005883) |
0.2 | 1.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 1.7 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 2.2 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 1.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 1.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 1.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 2.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.9 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.2 | 7.3 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 1.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.2 | 0.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.2 | 3.1 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.2 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.2 | 0.6 | GO:0031904 | endosome lumen(GO:0031904) |
0.2 | 1.6 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 0.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 1.7 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.2 | 4.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.2 | 4.3 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.2 | 0.6 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
0.2 | 0.7 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 0.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 2.2 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 1.1 | GO:0002102 | podosome(GO:0002102) |
0.2 | 0.2 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 1.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.2 | 2.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 1.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 0.5 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.2 | 3.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.5 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 2.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 0.5 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 0.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.2 | 1.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 0.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.6 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 2.7 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.2 | 2.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 1.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.2 | 1.9 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 1.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.2 | 2.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.2 | 12.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 0.8 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 2.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 0.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 1.0 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.1 | 4.5 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.1 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 0.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.3 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.0 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 7.2 | GO:0030426 | growth cone(GO:0030426) |
0.1 | 3.6 | GO:0030175 | filopodium(GO:0030175) |
0.1 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 2.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.9 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.1 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 16.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.7 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 1.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.1 | 1.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 1.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 3.0 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 1.6 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 2.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 2.9 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 1.8 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.4 | GO:0032059 | bleb(GO:0032059) |
0.1 | 0.5 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.7 | GO:0043679 | axon terminus(GO:0043679) |
0.1 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.6 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.4 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 0.2 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 13.8 | GO:0005819 | spindle(GO:0005819) |
0.1 | 1.4 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.1 | 0.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 11.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 4.1 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.1 | 0.2 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.6 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 0.2 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 1.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.1 | GO:0030425 | dendrite(GO:0030425) |
0.1 | 1.6 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 2.0 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 2.2 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.1 | GO:0043005 | neuron projection(GO:0043005) |
0.1 | 0.1 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.3 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.3 | GO:0000792 | heterochromatin(GO:0000792) |
0.1 | 0.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.8 | GO:0031090 | organelle membrane(GO:0031090) |
0.1 | 9.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 5.1 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.3 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
0.1 | 4.3 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.1 | 2.4 | GO:0031674 | I band(GO:0031674) |
0.1 | 1.5 | GO:0036064 | ciliary basal body(GO:0036064) |
0.1 | 0.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 3.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 3.6 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.4 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.1 | GO:0044215 | host(GO:0018995) host cell part(GO:0033643) host intracellular part(GO:0033646) intracellular region of host(GO:0043656) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 6.0 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 2.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 3.5 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 0.5 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 1.2 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.8 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.1 | 1.1 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 7.6 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.1 | 12.1 | GO:0005635 | nuclear envelope(GO:0005635) |
0.1 | 0.5 | GO:0030990 | intraciliary transport particle(GO:0030990) |
0.1 | 5.4 | GO:0019717 | obsolete synaptosome(GO:0019717) |
0.1 | 4.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 1.1 | GO:0034706 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.1 | 1.0 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.3 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.1 | 0.3 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 2.9 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 1.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 2.8 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.5 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.2 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 9.3 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 2.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 21.0 | GO:0005625 | obsolete soluble fraction(GO:0005625) |
0.1 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.1 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 0.6 | GO:0032156 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.1 | 0.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 1.2 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.1 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.2 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 16.5 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.1 | 0.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.1 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 2.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.8 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 1.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 291.1 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.1 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.1 | 0.1 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
0.1 | 0.2 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.7 | GO:0055037 | recycling endosome(GO:0055037) |
0.1 | 0.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.7 | GO:0005768 | endosome(GO:0005768) |
0.1 | 20.0 | GO:0031967 | organelle envelope(GO:0031967) |
0.1 | 26.2 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 0.7 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 0.1 | GO:0002141 | stereocilia coupling link(GO:0002139) stereocilia ankle link(GO:0002141) stereocilia ankle link complex(GO:0002142) |
0.1 | 0.3 | GO:0016234 | inclusion body(GO:0016234) |
0.1 | 25.3 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 0.8 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.3 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 5.2 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 1.3 | GO:0031982 | vesicle(GO:0031982) |
0.1 | 28.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 3.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 1.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 2.9 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.2 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.1 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 0.2 | GO:0031253 | cell projection membrane(GO:0031253) |
0.1 | 0.6 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 32.8 | GO:0005829 | cytosol(GO:0005829) |
0.1 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.1 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 2.3 | GO:0030529 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.5 | GO:0030141 | secretory granule(GO:0030141) |
0.1 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.1 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.1 | 0.6 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.0 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 4.1 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 2.1 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 1.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.0 | 0.1 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.0 | 0.2 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 2.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.0 | 0.2 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.3 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.3 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.0 | 1.0 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 93.9 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.0 | GO:0070695 | FHF complex(GO:0070695) |
0.0 | 0.1 | GO:0005792 | obsolete microsome(GO:0005792) |
0.0 | 6.2 | GO:0005886 | plasma membrane(GO:0005886) |
0.0 | 0.4 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.0 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.0 | 17.7 | GO:0005622 | intracellular(GO:0005622) |
0.0 | 0.1 | GO:0005929 | cilium(GO:0005929) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.7 | 2.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.7 | 2.7 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 1.9 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.6 | 1.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.6 | 3.0 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.6 | 1.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.6 | 2.4 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 1.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.6 | 1.7 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.6 | 3.4 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.5 | 2.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.5 | 1.6 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.5 | 1.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.5 | 4.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 1.4 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.5 | 2.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.5 | 0.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.5 | 1.4 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.5 | 1.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.5 | 1.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.5 | 2.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 1.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.4 | 1.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 1.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.4 | 1.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.4 | 1.3 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.4 | 0.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.4 | 4.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.4 | 1.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.4 | 2.5 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 1.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.4 | 1.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.4 | 2.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 0.4 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.4 | 1.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.4 | 2.8 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.4 | 1.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 1.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 1.5 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.4 | 0.8 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 1.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.4 | 1.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 1.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 1.5 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.4 | 0.7 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.4 | 1.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.4 | 2.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.4 | 1.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.4 | 1.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.4 | 0.7 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.4 | 1.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.4 | 2.1 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.4 | 2.1 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 1.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 1.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 1.0 | GO:0019863 | IgE binding(GO:0019863) |
0.3 | 1.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.3 | 0.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.3 | 3.4 | GO:0030276 | clathrin binding(GO:0030276) |
0.3 | 0.7 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.3 | 1.0 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.3 | 0.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.3 | 2.0 | GO:0070402 | NADPH binding(GO:0070402) |
0.3 | 1.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.3 | 1.0 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.3 | 1.0 | GO:0050693 | LBD domain binding(GO:0050693) |
0.3 | 1.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.3 | 5.7 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.3 | 1.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.3 | 1.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.3 | 0.3 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.3 | 1.3 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.3 | 0.6 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) |
0.3 | 1.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 1.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 1.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.3 | 1.6 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 0.3 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.3 | 0.9 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.3 | 1.9 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.3 | 0.3 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.3 | 0.6 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.3 | 0.3 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 1.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 0.3 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.3 | 0.9 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.3 | 1.8 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.3 | 5.3 | GO:0043621 | protein self-association(GO:0043621) |
0.3 | 5.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.3 | 1.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 0.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.3 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 3.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 4.1 | GO:0005035 | death receptor activity(GO:0005035) |
0.3 | 1.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 0.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.3 | 0.9 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.3 | 1.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 0.8 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 1.4 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.3 | 0.8 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.3 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 0.8 | GO:0031404 | chloride ion binding(GO:0031404) |
0.3 | 0.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.3 | 1.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 0.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.3 | 1.6 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 0.8 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 0.8 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.3 | 1.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 1.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.3 | 2.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.3 | 1.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 3.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 2.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.3 | 0.8 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 1.8 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.3 | 0.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 0.8 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 1.8 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 0.8 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.3 | 4.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 1.0 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 0.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 1.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.3 | 0.8 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 1.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.3 | 0.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.3 | 1.8 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.2 | 1.2 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.2 | 1.0 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 1.0 | GO:0004340 | glucokinase activity(GO:0004340) |
0.2 | 1.5 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 1.0 | GO:0042153 | obsolete RPTP-like protein binding(GO:0042153) |
0.2 | 3.2 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 0.7 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.2 | 1.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.2 | 0.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 1.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.2 | 1.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 0.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.7 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.2 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 2.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 0.5 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 1.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.2 | 8.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 3.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 3.2 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.2 | 2.7 | GO:0005548 | phospholipid transporter activity(GO:0005548) |
0.2 | 2.7 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.2 | 0.9 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.2 | 9.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 1.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 1.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 2.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.9 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.2 | 0.7 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.2 | 0.7 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 1.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 0.6 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 1.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 2.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.2 | 0.9 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 0.8 | GO:0015925 | galactosidase activity(GO:0015925) |
0.2 | 0.2 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 1.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.2 | 1.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 4.2 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 3.4 | GO:0051117 | ATPase binding(GO:0051117) |
0.2 | 1.0 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 1.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 1.0 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.2 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.6 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.2 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.2 | 1.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 0.6 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.2 | 0.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 2.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.6 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.2 | 1.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 0.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 1.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.2 | 23.0 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.2 | 0.4 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.2 | 1.9 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 1.1 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 0.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.2 | 0.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 2.4 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.2 | 3.0 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.2 | 0.6 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.2 | 1.1 | GO:0031432 | titin binding(GO:0031432) |
0.2 | 2.6 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.2 | 0.6 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 2.9 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.2 | 1.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.5 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.2 | 1.3 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.2 | 1.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 1.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 2.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 1.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.5 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.2 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.2 | 1.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 1.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.5 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.2 | 1.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 3.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 5.1 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.2 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 2.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
0.2 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 1.7 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.2 | 0.5 | GO:0004875 | complement receptor activity(GO:0004875) |
0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 0.7 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.2 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 3.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 3.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 2.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 0.3 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.2 | 0.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.2 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.7 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 0.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 1.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 1.0 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.2 | 4.2 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.2 | 0.5 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.2 | 0.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 1.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 1.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.2 | 0.6 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 1.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.4 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 0.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 0.2 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.2 | 0.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.2 | 4.2 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 0.6 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 0.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.2 | 1.7 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 1.8 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.2 | 0.6 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 0.5 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.2 | 0.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 0.3 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.1 | 2.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.6 | GO:0016803 | epoxide hydrolase activity(GO:0004301) ether hydrolase activity(GO:0016803) |
0.1 | 2.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 1.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 1.8 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 1.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.9 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.1 | 0.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.1 | 0.6 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 3.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.7 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.3 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.1 | 0.7 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 1.3 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 1.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 5.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 0.4 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.1 | 0.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.7 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 1.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0031544 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.1 | 3.2 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 1.7 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.5 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 0.8 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.5 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 13.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.4 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 2.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 0.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 8.9 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.4 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.4 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.4 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 1.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.0 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 23.0 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.1 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 3.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.4 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 2.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.6 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 12.8 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.1 | 1.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.5 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 1.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.2 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.5 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 0.7 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.4 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 3.7 | GO:0101005 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 0.8 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 1.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 1.1 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) ubiquitin binding(GO:0043130) |
0.1 | 1.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.6 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.1 | 0.9 | GO:0030515 | snoRNA binding(GO:0030515) |
0.1 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.7 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 4.0 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.2 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 3.8 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.1 | 0.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.3 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 1.1 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.4 | GO:0005123 | death receptor binding(GO:0005123) tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 1.9 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 6.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 0.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 1.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.5 | GO:0045296 | cadherin binding(GO:0045296) |
0.1 | 0.7 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.3 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.1 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 2.8 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.1 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.1 | 0.1 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 1.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 5.9 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.1 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 1.2 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.1 | 0.2 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 0.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 0.8 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.7 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 1.1 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.1 | 3.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.1 | 2.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.3 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.3 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 1.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.3 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.3 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 2.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.2 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 2.3 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 0.9 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.1 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.5 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.1 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 0.1 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.1 | 0.4 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.1 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.4 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.1 | 0.3 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.4 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.1 | 3.3 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 0.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 3.6 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 20.8 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.1 | 1.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.2 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.1 | 5.4 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.1 | GO:0004396 | hexokinase activity(GO:0004396) |
0.1 | 0.3 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.7 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 1.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.1 | 2.7 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.2 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.2 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.1 | 0.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.1 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 1.5 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 22.2 | GO:0019001 | guanyl nucleotide binding(GO:0019001) guanyl ribonucleotide binding(GO:0032561) |
0.1 | 0.5 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 0.1 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.1 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.1 | 0.4 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 0.8 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.1 | GO:0034594 | phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
0.1 | 0.1 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.9 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 0.4 | GO:0031543 | peptidyl-proline dioxygenase activity(GO:0031543) |
0.1 | 0.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 2.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.3 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.2 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
0.1 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 2.6 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.6 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.1 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.4 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.4 | GO:0015923 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.8 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 0.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 0.2 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 1.0 | GO:0005227 | calcium activated cation channel activity(GO:0005227) ion gated channel activity(GO:0022839) |
0.1 | 1.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.1 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 6.3 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 9.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 26.7 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.2 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.5 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 0.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 0.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.1 | 95.0 | GO:0008270 | zinc ion binding(GO:0008270) |
0.1 | 0.1 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.1 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.8 | GO:0004673 | phosphorelay sensor kinase activity(GO:0000155) protein histidine kinase activity(GO:0004673) |
0.1 | 0.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.8 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 0.1 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.1 | 0.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 11.6 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.1 | 0.4 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.5 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.1 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.9 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 1.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 1.1 | GO:0051287 | NAD binding(GO:0051287) |
0.1 | 1.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 1.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.5 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.9 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.1 | GO:0008493 | tetracycline transporter activity(GO:0008493) |
0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 0.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.1 | 5.5 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.1 | 0.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.2 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.2 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 0.4 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 1.0 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.1 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.1 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
0.1 | 0.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.2 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.1 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.3 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 3.4 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.6 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.0 | 0.8 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.0 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.0 | 0.0 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.0 | 0.2 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.0 | 2.8 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.0 | 0.2 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.0 | 0.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.0 | 0.2 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.0 | 0.4 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.0 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 2.7 | GO:0019900 | kinase binding(GO:0019900) |
0.0 | 2.5 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.4 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.9 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.0 | 0.6 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.0 | 0.9 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.0 | 0.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 0.1 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.0 | 0.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 0.5 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.2 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.0 | 2.0 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.2 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.0 | 0.6 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 5.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.4 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.1 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.1 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.0 | 13.8 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.1 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 3.6 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.0 | 0.0 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.5 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 2.7 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.0 | 2.6 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.0 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0015421 | oligopeptide-transporting ATPase activity(GO:0015421) |
0.0 | 0.7 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.1 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.7 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.0 | 0.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.1 | GO:0008106 | alcohol dehydrogenase (NADP+) activity(GO:0008106) |
0.0 | 0.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.0 | 0.0 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.0 | 0.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.4 | GO:0032934 | sterol binding(GO:0032934) |
0.0 | 0.2 | GO:0016878 | acid-thiol ligase activity(GO:0016878) |
0.0 | 0.2 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.5 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.0 | 0.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.5 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.0 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.0 | 0.5 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.3 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.3 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.8 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 3.1 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.1 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
0.0 | 0.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 0.1 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.2 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 0.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.0 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.0 | 0.0 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.7 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 4.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.2 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.0 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.0 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.2 | GO:0005496 | steroid binding(GO:0005496) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 25.3 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 3.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.4 | 3.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 7.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 1.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.4 | 7.4 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 5.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.3 | 2.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 9.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 3.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.3 | 4.3 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 4.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.3 | 0.6 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.3 | 4.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 0.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 1.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.2 | 3.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 4.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 1.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 3.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 4.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.2 | 2.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.2 | 4.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 4.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 3.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 2.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 2.9 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 0.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 3.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 1.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.2 | 2.9 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.2 | 4.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 1.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 3.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 2.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.2 | 1.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.2 | 5.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 2.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 2.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 5.2 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 1.6 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 3.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 4.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 0.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 4.9 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 0.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 2.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 0.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.2 | 2.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.2 | 3.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 1.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 7.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 1.2 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 1.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 3.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 8.5 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 4.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 4.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.7 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 3.2 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 0.7 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.6 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 2.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.1 | 3.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 6.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 1.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.7 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 2.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 2.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 1.3 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 3.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.8 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 0.2 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 1.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 1.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.2 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 1.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.1 | 2.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 1.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 1.0 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 3.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 0.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 3.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.1 | 1.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 0.4 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.2 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 3.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 0.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.8 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
0.0 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.2 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.0 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 3.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 3.5 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 0.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.7 | 0.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.5 | 1.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.5 | 0.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.5 | 5.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 4.6 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.4 | 0.4 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.4 | 2.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.4 | 0.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 4.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 3.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.3 | 5.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 8.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 0.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.3 | 3.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.3 | 2.5 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
0.3 | 4.0 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.3 | 3.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 2.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 3.5 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 0.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.3 | 3.7 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.3 | 2.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 5.1 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.3 | 2.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 3.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 6.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 2.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 3.5 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 2.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 1.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 2.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 0.8 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 1.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 2.8 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.3 | 4.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 4.5 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.3 | 2.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 8.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 0.2 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.2 | 0.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 0.7 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.2 | 8.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 0.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.2 | 0.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.2 | 0.5 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 2.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 4.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 2.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 3.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 4.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.2 | 1.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 0.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.2 | 2.1 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 1.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.2 | 1.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 3.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.5 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.2 | 2.1 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 5.2 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 0.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 1.7 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 1.5 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 3.5 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 0.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 2.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.2 | 0.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.2 | 0.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 1.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 1.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 3.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.2 | 0.8 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.2 | 2.4 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.2 | 3.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 0.8 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.2 | 2.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 1.3 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.2 | 0.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 5.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.2 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.2 | 3.9 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.2 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 0.3 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.2 | 0.5 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.2 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 0.9 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 0.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 2.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 4.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.2 | 0.2 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.2 | 1.7 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.2 | 1.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 1.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 2.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.6 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 2.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 10.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.1 | 0.6 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.1 | 1.9 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.1 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 3.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.8 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 1.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 3.0 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 0.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 7.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 2.1 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 2.8 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 2.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 2.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 0.5 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 2.8 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 2.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 1.0 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.1 | 1.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 5.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 2.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 0.1 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 0.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.1 | 1.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 2.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.5 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.1 | 0.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 6.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 0.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 1.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 4.3 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 0.6 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.4 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 1.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 3.6 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.3 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.1 | 0.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 23.8 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 4.5 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 5.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.3 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.1 | 5.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 0.8 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.0 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 0.4 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 1.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 9.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 1.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 1.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 1.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 3.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.3 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.1 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 3.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.1 | 1.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 1.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 2.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.6 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 3.3 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.1 | 0.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.9 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.1 | 3.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.4 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 0.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 4.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.5 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 1.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 6.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 0.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.5 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.2 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.1 | 3.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.3 | REACTOME INSULIN RECEPTOR SIGNALLING CASCADE | Genes involved in Insulin receptor signalling cascade |
0.1 | 1.1 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.3 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 0.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.1 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 1.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.4 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.8 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 0.5 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.9 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.0 | 1.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.2 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.3 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.0 | 1.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.4 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.4 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.0 | 0.2 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.5 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.0 | 0.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.1 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 1.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.0 | 1.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.3 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.6 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.1 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.1 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 0.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.3 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.4 | REACTOME PHOSPHOLIPID METABOLISM | Genes involved in Phospholipid metabolism |
0.0 | 0.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.0 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.0 | 0.1 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.0 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.1 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.3 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |